Insel Gruppe Ag, University Hospital Bern

This study tests whether people with giant cell arteritis (a type of blood vessel inflammation) can safely stop steroids after 8 weeks instead of the usual 26 weeks, when also taking the drug tocilizumab. The goal is to see if the shorter course works just as well to prevent rela…

This study tests whether semaglutide (a GLP-1 drug used for diabetes and weight loss) can help people with obesity and fatty liver disease stop drinking alcohol. About 64 participants will receive either semaglutide or a placebo, plus counseling, for 16 weeks. The main goal is to…

This study will compare the effects of synthetic nicotine and nicotine analogues to traditional tobacco-derived nicotine in 24 adults who regularly vape. Researchers will measure how much of these substances get into the blood and how the body processes them. The goal is to bette…

This study looks at how sleep apnea measurements vary from night to night when people test at home. Researchers will track 192 adults with suspected or known sleep apnea over multiple nights using standard and new monitoring methods. The goal is to find which measurements are mos…

This study asks children aged 6-16, their parents, and healthcare workers to vote on the most important research topics in pediatric anesthesia and surgery care. The goal is to create a shared list of top 10 priorities to guide future studies. No treatments or medications are tes…

This study looks at whether turning on a cochlear implant helps adults with hearing loss better understand where they are in space. Researchers will test balance and orientation with the implant on and off. The goal is to learn if the implant's hearing benefits also improve spati…

This study looks at how taking a mix of probiotics (good bacteria) changes the gut microbiome in 40 children and teens with inflammatory bowel disease (IBD). Participants will take probiotics and a placebo at different times to compare effects. The goal is to understand, not trea…

This study tests whether the Stockholm3 blood test can accurately detect when low-risk prostate cancer becomes more aggressive in men who are closely monitored instead of treated immediately. Researchers will compare the test's results to follow-up biopsies in 350 men. If success…